succinic acid has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)
succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Succinic Acid has some positive biological properties." | 5.31 | [Diabetes mellitus in the elderly: succinic acid compounds in treating diabetic neuropathies]. ( Belikova, TV; Odin, VI; Pushkova, ES, 2002) |
| "Succinic Acid has some positive biological properties." | 1.31 | [Diabetes mellitus in the elderly: succinic acid compounds in treating diabetic neuropathies]. ( Belikova, TV; Odin, VI; Pushkova, ES, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kharitonova, T | 1 |
| Shvarts, YG | 1 |
| Verbovoy, AF | 1 |
| Orlova, NS | 1 |
| Puzyreva, VP | 1 |
| Strokov, IA | 1 |
| Odin, VI | 1 |
| Belikova, TV | 1 |
| Pushkova, ES | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter, Double-blind, Placebo-controlled Randomized Clinical Trial of Efficacy and Safety of the Drug Cytoflavin®, Administered Intravenously Followed by Oral Intake, in Patients With Diabetic Polyneuropathy[NCT04649203] | Phase 3 | 216 participants (Actual) | Interventional | 2020-11-25 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for succinic acid and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (C
Topics: Antioxidants; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Inosine; Male; Niaci | 2022 |
1 other study available for succinic acid and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
[Diabetes mellitus in the elderly: succinic acid compounds in treating diabetic neuropathies].
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Male; Middle | 2002 |